Our 2018 Speakers

Lee Newcomer, MD, MHA

Lee Newcomer, MD, MHA

Dr. Newcomer, a board certified medical oncologist, was recently a senior vice president at UnitedHealthcare with strategic responsibility for Oncology and Genetics.

Dr. Newcomer earned a B.A. degree from Nebraska Wesleyan University, an M.D. degree from the University of Nebraska College of Medicine, and a masters of health administration from the University of Wisconsin at Madison. He completed his internship and residency in internal medicine at the University of Nebraska Medical Center and a fellowship in medical oncology at the Yale University School of Medicine.

Gautam Jha, MBBS

Gautam Jha, MBBS

Dr. Jha, is a board certified medical oncologist and Adjunct Assistant Professor for the Department of Medicine within Division of Hematology, Oncology, and Transplantation at the University of Minnesota. 

Dr. Jha is interested in developing therapies that would harness the strength of our immune system for treatment of cancer. Unfortunately there are no good treatment options for patients with advanced cancers despite ample evidence of immune-deregulation. Disrupting tumor-mediated immune suppression is the key to progress in these diseases with otherwise dismal outcomes. His research focuses on developing new immunotherapies for genitourinary cancers.

Taylor Monson, PharmD

Taylor Monson, PharmD

Dr. Monson is a PGY2 Hematology/Oncology Pharmacy Resident at Nebraska Medicine in Omaha, Nebraska.  She received her PharmD from Drake University and completed her PGY1 residency at Nebraska Medicine.  She is a member of The American Society of Health-System Pharmacists and a member of the Hematology Oncology Pharmacy Association.

Elizabeth Travers, PharmD

Elizabeth Travers, PharmD

Dr. Travers is a PGY-2 Hematology/Oncology Pharmacy Resident at Nebraska Medicine in Omaha, Nebraska. She received her PharmD from the Duquesne University Mylan School of Pharmacy in Pittsburgh, Pennsylvania and completed her PGY-1 at University Health Shreveport in Shreveport, Louisiana. She is a member of The American Society of Health-System Pharmacists and a member of the Hematology Oncology Pharmacy Association.

Mary Mably, RPh, BCOP

Mary Mably, RPh, BCOP

Mary is Pharmacy Manager, Inpatient Services and the PGY2 Oncology Pharmacy Program Director at University of Wisconsin Health in Madison, WI.  She received her BS in Pharmacy from St. Louis College of Pharmacy in 1983. She has worked for UW Health in Madison, WI since 2008 and has been Board Certified in Oncology Pharmacy since 2002. She serves on 2 NCCN panels and is an active member of HOPA and ASHP.  Mary was honored to receive the UW Health Pharmacy Department Preceptor of the Year Award in 2015 and the UW Department of Medicine Division of Hematology, Medical Oncology and Palliative Care Award for Extraordinary Service to the Division for 2016-17.  

Stacey Allen, MA, LMFT, CCLS

Stacey Allen, MA, LMFT, CCLS

Stacey has dedicated her professional life to working with individuals, couples, and families who have been affected by cancer both in her therapy practice at Healthwise Behavioral Health in Maple Grove, and in group support at Gilda’s Club Twin Cities.

Stacey specializes in psychosocial oncology, medical issues, chronic illness, and couple relationships and she is devoted to helping adults, children, teens, and families through all forms of loss, including grief.

 

Our 2017 Speakers

Pamala Jacobson, PharmD

Pamala Jacobson, PharmD

Dr Jacobson received a PharmD from the University of Nebraska followed by 2 years of postdoctoral training at the University of Michigan.   After completing her training she joined the faculty at the U of Michigan College of Pharmacy where she remained for 9 years.  She then joined the faculty at the University of Minnesota and is now Professor of Pharmacy in the Department of Experimental and Clinical Pharmacology in the College of Pharmacy.  Jacobson is a clinical pharmacologists specializing in clinical pharmacology and pharmacogenetics.  She investigates how genetic variation influences pharmacokinetics, efficacy and toxicity of anticancer and immunosuppressive agents.  She is the Director of the Institute of Personalized Medicine in the College of Pharmacy.

Linda Burns, MD

Linda Burns, MD

Dr. Burns is Vice President and Medical Director of the Medical Services Department at the National Marrow Donor Program/Be The Match and Senior Scientific Director of the Health Services Research Program within the Center for International Blood and Marrow Transplant Research in Minneapolis, MN.  Dr. Burns received her medical degree from the University of Missouri-Columbia, followed by a residency and chief-residency in Internal Medicine and a fellowship in Hematology/Oncology at the University of Iowa.  As a Professor of Medicine in the Adult Blood and Marrow Transplant Program at the University of Minnesota, her clinical research interests focused on development of novel therapies for  blood cancers such as leukemia and lymphoma, and the late effects of transplantation.  Dr. Burns was also President of the American Society of Hematology in 2014.

 

Mary Walters, PharmD

Mary Walters, PharmD

Dr. Walters is a PGY2 Oncology Pharmacy Resident in the Metro, Inc. Program at Aurora St Luke’s Medical Center in Milwaukee, Wisconsin.  Dr. Walters received her Bachelor of Arts in Chemistry with a Biochemistry Concentration from St. Catherine University in Saint Paul, Minnesota in 2012 and her PharmD from the University of Minnesota College of Pharmacy in Minneapolis, Minnesota in 2016. She completed PGY1 pharmacy practice residency at North Memorial Health Hospital in Robbinsdale, Minnesota in 2017.

Christine McNamara, PharmD

Christine McNamara, PharmD

Dr. McNamara is a PGY2 Oncology Pharmacy Resident at the Avera Cancer Institute at Avera McKennan Hospital and University Health Center in Sioux Falls, South Dakota.  Dr. McNamara completed her undergraduate degree at the University of Texas at Austin in 2011, earning a Bachelor’s of Science in Biology. She went on to earn her PharmD. from Texas Southern University in Houston, Texas. She then completed a PGY1 Hospital Pharmacy Residency at Avera McKennan Hospital and University Health Center in Sioux Falls, South Dakota. During her PGY1 she also earned a teaching certificate affiliated with South Dakota State University.

 

Leigh Boehmer, PharmD, BCOP

Leigh Boehmer, PharmD, BCOP

Dr. Boehmer (pronounced “Beemer”) is a Board Certified Oncology Pharmacist specializing in medical oncology at the Mercy Cancer Center in Mason City, Iowa. After graduating from the University of Iowa College of Pharmacy, he completed PGY1 and PGY2 oncology residencies at The Johns Hopkins Hospital. From there, he became an Assistant Professor in the Department of Clinical Pharmacy at the St. Louis College of Pharmacy in St. Louis, Missouri. He spent five years as an inpatient medical oncology clinical specialist at Barnes-Jewish Hospital before he and his family decided to relocate to North Iowa in 2015.

David Frenz, MD

David Frenz, MD

 

David Frenz earned a medical degree and completed a family medicine residency at the University of Minnesota. He is also board certified in addiction medicine. Dr. Frenz actively speaks, writes and consults on healthcare-related burnout and resilience. You can learn more about him and his work on LinkedIn.